Previous Article | Next Article 
Infection and Immunity, September 2000, p. 5139-5145, Vol. 68, No. 9
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Babesia bovis-Stimulated Macrophages
Express Interleukin-1
, Interleukin-12, Tumor Necrosis Factor Alpha,
and Nitric Oxide and Inhibit Parasite Replication In
Vitro
Lisl K. M.
Shoda,1
Guy H.
Palmer,1
Jorge
Florin-Christensen,1,2
Monica
Florin-Christensen,1
Dale L.
Godson,3 and
Wendy C.
Brown1,*
Program in Vector-Borne Diseases, Department
of Veterinary Microbiology and Pathology, Washington State University,
Pullman, Washington 99164-70401;
Institute of Neuroscience (CONICET), CC 137, RA-1663, San
Miguel, Argentina2; and Veterinary
Infectious Disease Organization, University of Saskatchewan, Saskatoon,
Saskatchewan, Canada3
Received 24 February 2000/Returned for modification 12 April
2000/Accepted 20 June 2000
 |
ABSTRACT |
The tick-transmitted hemoparasite Babesia bovis causes
an acute infection that results in persistence and immunity against challenge infection in cattle that control the initial parasitemia. Resolution of acute infection with this protozoal pathogen is believed
to be dependent on products of activated macrophages (M
), including
inflammatory cytokines and nitric oxide (NO) and its derivatives.
B. bovis stimulates inducible nitric oxide synthase (iNOS)
and production of NO in bovine M
, and chemical donors of NO inhibit
the growth of B. bovis in vitro. However, the induction of
inflammatory cytokines in M
by babesial parasites has not been
described, and the antiparasitic activity of NO produced by B. bovis-stimulated M
has not been definitively demonstrated. We
report that monocyte-derived M
activated by B. bovis
expressed enhanced levels of inflammatory cytokines interleukin-1
(IL-1
), IL-12, and tumor necrosis factor alpha that are important
for stimulating innate and acquired immunity against protozoal
pathogens. Furthermore, a lipid fraction of B. bovis-infected erythrocytes stimulated iNOS expression and NO
production by M
. Cocultures of M
and B. bovis-infected erythrocytes either in contact or physically
separated resulted in reduced parasite viability. However, NO produced
by bovine M
in response to B. bovis-infected
erythrocytes was only partially responsible for parasite growth
inhibition, suggesting that additional factors contribute to the
inhibition of B. bovis replication. These findings
demonstrate that B. bovis induces an innate immune response
that is capable of controlling parasite replication and that could
potentially result in host survival and parasite persistence.
 |
INTRODUCTION |
Understanding the cellular and
molecular basis for immunity to hemoparasitic diseases, such as
babesiosis and malaria, is central to devising safe and effective
therapeutics and vaccines. Innate immune mechanisms are hypothesized to
be important for the resolution of acute infection with these
parasites, whereas acquired immunity is likely more important for
resistance to homologous and heterologous parasite strain challenge
(9, 14). Parasite-activated M
inhibit parasite growth
during acute infection and contribute to the development of acquired
T-cell-mediated and humoral immunity by presenting antigen and
directing a type 1 immune response through the production of certain
cytokines. The mammalian stages of some protozoa, such as
Toxoplasma gondii, Trypanosoma cruzi, and
Trypanosoma brucei, activate M
to secrete oxygen
radicals, nitric oxide (NO), and inflammatory cytokines, including
interleukin-1 (IL-1), tumor necrosis factor alpha (TNF-
), and IL-12
(18, 32, 34, 45). Plasmodium falciparum also
stimulates M
to produce NO (32) and human peripheral
blood mononuclear cells (PBMCs) to produce enhanced levels of TNF-
,
IL-12, and gamma interferon (IFN-
) (35). In contrast, the
promastigote stage of Leishmania parasites fails to activate
these responses in murine M
(18). Thus, the ability of
specific parasites or parasitic stages to evade or induce M
activation may be a critical determinant in the outcome of acute
infection and the development of acquired immunity. We recently
determined that Babesia bovis-infected erythrocytes and a
membrane-enriched fraction of merozoites stimulated inducible nitric
oxide synthase (iNOS) transcription and NO production (37) by peripheral blood monocyte-derived M
of cattle. However, induction of inflammatory cytokines by B. bovis has not been demonstrated.
Cytokines, including IL-12 and TNF-
produced by M
and other
antigen-presenting cells, are critical for generating and regulating innate and acquired immune responses against many pathogens. IL-12 activates natural killer (NK) cells to produce IFN-
and contributes to the development of acquired immunity through its ability to promote
the differentiation of IFN-
-producing Th cells and to enhance
IFN-
production by differentiated Th cells (30, 41). IFN-
and TNF-
are also important for activating effector
functions of phagocytic cells. For example, TNF-
enhanced
neutrophil-mediated killing of mouse malarial parasites (24)
and, in concert with IFN-
, stimulated the production of NO by murine
and bovine M
(16). Because IFN-
activates M
, it is
hypothesized to be a key cytokine in the protective immune response to
Babesia parasites (9). Consistent with this,
Babesia-specific CD4+ T-cell lines and clones
derived from cattle protected against challenge secreted IFN-
(5, 43). In addition, supernatants from B. bovis-stimulated CD4+ T-cell lines that contained
IFN-
and TNF-
induced NO production by bovine M
(37). These observations raise the question of whether
B. bovis merozoites can stimulate the induction of cytokines in M
that participate in inflammatory responses and prime for type 1 CD4+ T cells.
In response to acute infection with B. bovis, activated M
are believed to kill parasites by phagocytosis and through production of soluble toxic mediators, including NO, peroxynitrite, and
superoxide. Evidence for nonphagocytic inhibition of B. bovis includes in vitro growth inhibition by soluble factors from
cultured M
(28) and babesiacidal activity of chemical
donors of NO (23). Similar results were reported for related
malarial parasites (31, 40). While these results strongly
suggest that M
-derived NO produced in response to B. bovis controls parasite growth, this has not been definitively demonstrated.
Although both TNF-
and NO likely function as elements of protective
immunity against hemoprotozoan parasites, overproduction of these
molecules has been implicated in the pathological sequelae of disease
(21, 45). Therefore, rational vaccine design is critically
dependent on characterizing M
cytokine induction by B. bovis, which may result in either severe pathology or resolution of acute infection and development of a long-lasting protective immunity. The studies reported here were undertaken to identify the
cytokines induced by B. bovis-infected erythrocytes and to determine whether parasite lipids activate M
. In addition, we have
attempted to define the contribution of NO to parasite growth inhibition by B. bovis-activated M
.
 |
MATERIALS AND METHODS |
Culture of B. bovis and lipid extraction.
The
Mexico strain of B. bovis was cultured in bovine
erythrocytes obtained from Babesia-negative donors (7,
37). All parasite cultures tested negative for endotoxin (<6
pg/ml) by using the Limulus amebocyte lysate assay
(Whittaker M.A. Bioproducts, Walkersville, Md.), and all were negative
for Mycoplasma when tested by PCR with a kit from Stratagene
(La Jolla, Calif.) as previously described (37). Lipids were
extracted from B. bovis-infected erythrocytes as previously
described (3). Briefly, a chloroform-methanol extraction,
yielding a final ratio of 1:1:0.9 (chloroform:methanol:water [vol/vol/vol]), was performed. The organic fraction was collected, evaporated under nitrogen, and quantified. The same extraction procedure was conducted with uninfected erythrocytes as a control.
Culture of bovine monocyte-derived M
.
Monocyte-derived
M
were isolated from PBMCs from two Babesia-naïve
donor cattle by plastic adherence and culturing for 6 days as
previously described (37). After 6 days of culture, M
were harvested and used for NO and cytokine induction assays and
parasite growth inhibition assays.
Analysis of iNOS and cytokine mRNA by RT-PCR.
M
were
cultured for 6 h in 24-well plates at a concentration of 5 × 105 cells per well in 0.5 ml of complete RPMI 1640 medium
and infected red blood cells (IRBCs) at a final concentration of 10%
packed cell volume (PCV) and 10% parasitized erythrocytes (PE) in the presence or absence of 50 U of recombinant bovine IFN-
(Ciba-Geigy; kindly provided by Lorne Babiuk, Veterinary Infectious Disease Organization [VIDO], Saskatoon, Saskatchewan, Canada) per ml. As a
negative control, equivalent numbers of uninfected RBCs (URBCs) from
the same donor were added to the M
cultures. As a positive control,
M
were similarly incubated with 100 ng of lipopolysaccharide (LPS)
per ml from Escherichia coli O55:B5 (Sigma Chemical Co., St.
Louis, Mo.) plus 50 U of IFN-
per ml. RNA was isolated, treated with
DNase (Ambion, Inc., Austin, Tex.), and analyzed for iNOS and cytokine
expression by reverse transcription-PCR (RT-PCR) as previously
described (36). The primers for bovine IL-1
, IL-10, IL-12
p40, IL-12 p35, IL-18, iNOS, TNF-
, and
-actin are listed in Table
1. The cycle number chosen for each
primer set was empirically determined for each set of samples, based on
the positive control (i.e., LPS plus IFN-
-treated sample), and was selected to fall within the linear range of amplification. Samples were
compared by normalizing the target signal to the
-actin signal from
each sample and then comparing the normalized values.
NO2
detection by the Griess
reaction.
M
were cultured for 2 days at a concentration of
105 cells per well of 96-well flat-bottom plates with 5 to
125 µg of lipid per ml prepared from URBCs or IRBCs, without or with
50 U of IFN-
per ml, 10 µg of polymyxin B (Sigma) per ml, or 250 µM L-arginine competitor,
NG-monomethyl-L-arginine (L-NMMA;
Calbiochem, La Jolla, Calif.). Culture supernatants were transferred
(50 µl per well) to new 96-well, flat-bottom plates, and 50 µl of
1% sulfanilamide (Sigma) in 2.5% H3PO4 per
well followed by 50 µl 0.1% (wt/vol) naphthylethylenediamine dihydrochloride (Sigma) in 2.5% H3PO4 per well
were added to the supernatants; the A540 was
compared to a NaNO2 standard curve. Results are presented
as the mean micromolar concentration of nitrite
(NO2
) in quadruplicate cultures ± 1 standard deviation (SD). The Student one-tailed t test was
used to determine statistically significant differences in
NO2
production.
TNF-
detection by ELISA.
M
were cultured for 24 h
with URBCs or IRBCs (10% PCV; 10% PE) or with 100 ng of LPS per ml,
with or without 50 U of IFN-
per ml. Supernatants were serially
diluted (twofold up to 1:128) and compared by enzyme-linked
immunosorbent assay (ELISA) with recombinant bovine TNF-
diluted
from 0.04 to 10 ng per ml as a standard. A capture ELISA for bovine
TNF-
was used as previously described (12) with the
following modifications. Immulon II ELISA plates (Dynax Technologies,
Chantilly, Va.) were coated with 100 µl of anti-bovine TNF-
monoclonal antibody 1D11-13 (VIDO) diluted 1:1,000 in carbonate buffer
(pH 9.5) overnight at 4°C. Plates were washed six times with TBST (10 mM Tris, 150 mM NaCl, 0.05% Tween-20, pH 7.6). Samples serially
diluted in TBST-g (TBST containing 0.5% gelatin) were added to the
plates and incubated for 2 h at room temperature or overnight at
4°C. Plates were washed with TBST. Rabbit anti-TNF-
serum (VIDO)
diluted 1:1,500 in PBS-g (PBS containing 0.5% gelatin) was added for
1 h at room temperature. Plates were washed with TBST, and
biotinylated goat anti-rabbit IgG (H+L chains; Zymed Laboratories, San
Francisco, Calif.) diluted 1:10,000 in PBS-g was added for 1 h at
room temperature. Plates were washed in TBST, and strepavidin-alkaline
phosphatase (GIBCO, Rockville, Md.) diluted 1:2,000 in PBST-g was added
for 1 h at room temperature. Plates were washed, and substrate
p-nitrophenyl phosphate di(Tris) salt crystalline (PNPP)
diluted to 1 mg per ml in 1% diethanolamine with 0.5 mM
MgCl2 (pH 9.8) was added. The reaction was stopped by
addition of 30 µl of 0.3 M EDTA (pH 8.0) per well, and the optical
density at 405 nm was determined with an ELISA plate reader. The
Student one-tailed t test was used to determine
statistically significant differences in TNF-
production.
IL-12 detection by bioassay.
IL-12 activity was evaluated
based on its ability to stimulate IFN-
production in normal bovine
PBMCs (4, 36). M
culture supernatants (1:2) or
recombinant human IL-12 (rHuIL-12) (0.001 to 1.0 ng per ml; kindly
provided by Genetics Institute, Inc., Cambridge, Mass.) was added to
PBMCs stimulated with 1 µg of phytohemagglutinin (PHA; Sigma) per ml
and cultured at 2 × 106 cells per ml in 48-well
plates. PBMC supernatants were collected after 48 h and stored at
70°C until analysis. IFN-
production by PBMCs was measured using
a commercial ELISA according to the manufacturer's instructions (CSL
Limited, Parkville, Victoria, Australia). IFN-
activity was
determined from a standard curve derived with a T-cell supernatant
estimated, by the vesicular stomatitus virus cytopathic effect
reduction assay, to contain 440 U of IFN-
per ml. The limit of
sensitivity was 0.275 U per ml. M
supernatants were also evaluated
for residual exogenous IFN-
, as some M
cultures received a final
concentration of 50 U of recombinant bovine IFN-
(rBoIFN-
) per
ml. The Student one-tailed t test was used to determine
statistically significant differences in IFN-
-inducing activity.
IL-1 detection by bioassay.
IL-1 activity was assessed by
the ability to enhance the proliferative response of mitogen-stimulated
mouse thymocytes. Briefly, thymocytes from two 4- to 6-week-old C3H/HeJ
mice were harvested, pooled, and plated at 106 cells per
well in 96-well flat-bottom plates. M
supernatants (1:4, 1:8, 1:16)
or rHuIL-1
(Peprotech, Inc., Rocky Hill, N.J.) were added with an
optimal concentration (8 µg per ml) of PHA and incubated for 72 h. [3H]thymidine (0.25 µCi) was added to each well
during the last 6 h of culture, and incorporation of radioactivity
was determined on a beta plate reader (Wallac, Gaithersburg, Md.).
Parasite growth inhibition assays.
Three different
approaches were used to measure the effect of NO on inhibition of
B. bovis replication. First, sodium nitroprusside (SNP;
Sigma) was used as a chemical donor of NO. Quadruplicate wells of
B. bovis-infected erythrocytes (10% PCV, 10% PE) were established with various concentrations of SNP (1 to 1,000 µM) in
96-well flat-bottom plates and cultured for 2 days. For the last 6 h of culture, 50 µCi of [3H]hypoxanthine (Amersham,
Cleveland, Ohio) was added to each well to measure parasite replication
(20). Cells were harvested, and incorporation of
radioactivity was determined by liquid scintillation counting. In
parallel experiments, NO production by SNP was assessed after 2 days by
using the Griess assay to analyze NO2
.
Second, M

were cultured in quadruplicate wells of 96-well plates at
10
5 cells per well with
B. bovis (10% PCV; 10%
PE) without and with
250 µM
L-NMMA, and growth inhibition
was determined by incorporation
of 50 µCi of
[
3H]hypoxanthine added during the last 6 h of
culture. Inhibition
of
B. bovis growth by bovine M

was
determined as the difference
between incorporation by
B. bovis alone and incorporation by
B. bovis in the
presence of bovine M

. Controls included URBCs or
M

cultured
alone. Uptake of radioactivity by M

was low (<2,000
cpm per well
containing 10
5 cells), and uptake by URBCs was negative
(<500 cpm per well for
10% PCV). Inhibition by M

was compared with
inhibition by M
plus
L-NMMA. The general formula for
parasite growth inhibition
was as follows:
Since percent inhibition was calculated as a function of average
populations, the standard deviation for percent inhibition
was
calculated according to the following general formula:
Third, a two-compartment culture system was also employed to
measure the effect of soluble M

products on parasite replication,
essentially as described by Quakyi et al. (
29).
B. bovis-infected
erythrocytes (10% PCV; 10% PE) were cultured in
24-well plates
and were physically separated from bovine M

(10
5 cells in 100 µl) cultured on a 0.4-µm-pore-size
membrane in a
cell culture insert (Costar, Cambridge, Mass.). After 2 days of
culture,
B. bovis-infected erythrocytes were
transferred to quadruplicate
wells of a 96-well flat-bottom plate,
radiolabeled with [
3H]hypoxanthine, harvested, and
counted. The Student one-tailed
t test was used to compare
parasite growth in the presence and
absence of
L-NMMA.
 |
RESULTS AND DISCUSSION |
Induction of inflammatory cytokines in M
by B. bovis.
We examined cytokines produced by activated M
that are known to
regulate NO production and to participate in the acquisition of type 1 immune responses. As observed previously for LPS-activated and LPS plus
IFN-
-activated M
(32), IL-18 was constitutively expressed and not upregulated upon B. bovis stimulation
(data not shown). However, B. bovis did induce
transcriptional upregulation of IL-12 p40 and IL-12 p35 in the absence
or presence of IFN-
(Fig. 1A). The
inflammatory cytokines IL-1
and TNF-
were also induced upon M
exposure to B. bovis in the absence (Fig. 1B) or presence
(Fig. 1C) of IFN-
. As depicted in Fig. 1B and 1C, the requirement
for IFN-
was not absolute but varied by M
preparation. Both
patterns were repeatedly observed. The induction of these cytokine
transcripts paralleled B. bovis-induced upregulation of iNOS
mRNA (37). IL-10, which has been shown to downregulate bovine IFN-
expression (4), was not upregulated in
response to B. bovis (data not shown). URBCs had no effect
on cytokine expression.

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 1.
B. bovis enhances transcription of cytokine
mRNA in bovine M . M were cultured for 6 h with URBCs or
IRBCs in the presence or absence of 50 U of IFN- per ml or with LPS
plus IFN- . RNA was isolated, subjected to DNase treatment, and
analyzed by RT-PCR. (A) Analysis of IL-12 p40, IL-12 p35, and
-actin. (B and C) Analysis of IL-1 , TNF- , and -actin. The
data in each panel are representative of three independent
experiments.
|
|
An ELISA specific for bovine TNF-

was employed to verify the
stimulation of TNF-

protein production by
B. bovis. M

cultured
with
B. bovis in the absence or presence of IFN-

produced TNF-

,
whereas control supernatants from M

cultured with
URBC did not
(Fig.
2). When
B. bovis-infected erythrocytes induced TNF-

production,
IFN-

potentiated the effect. However, similar to the RT-PCR data,
some M

preparations did not respond to
B. bovis alone but required
the presence of exogenous IFN-

(data not shown).

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 2.
TNF- production by M stimulated with B. bovis. M were cultured for 24 h with URBCs, IRBCs, or LPS
in the presence or absence of 50 U of IFN- per ml. Supernatants were
tested by ELISA and compared with recombinant bovine TNF- as a
standard. Results are presented as the mean ± 1 SD of duplicate
determinations and are representative of three independent experiments
performed with M from different cattle. *, P < 0.05, for M cultured with LPS alone or plus IFN- compared to
M cultured with medium or IFN- alone, respectively. #,
P < 0.05, for M cultured with IRBCs alone or plus
IFN- compared to M cultured with URBCs alone or URBCs plus
IFN- , respectively.
|
|
To evaluate functional IL-12 production in response to
B. bovis, a bioassay was employed based on the ability of IL-12 to
induce IFN-

production by bovine PBMCs costimulated with PHA
(
4,
36). Supernatants from M

cultured with
B. bovis in the
absence or presence of IFN-

were capable of
inducing significant
amounts of IFN-

by PBMCs, whereas supernatants
from M

cultured
with URBCs contained little or no IFN-

-inducing
activity (Fig.
3). IFN-

levels in the
macrophage supernatants were all <3 U
per ml (data not shown). While
these data strongly indicate that
the supernatants contained IL-12, the
possibility that IL-18 contributed
to the observed effect cannot be
ruled out.

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 3.
IL-12-like activity is present in supernatants from M
treated with IRBCs in the absence or presence of IFN- . Bovine M
were cultured for 24 h with URBCs or IRBCs (10% PE, 10% PCV) in
the absence or presence (+) of 50 U of IFN- per ml. M were
cultured with medium or IFN- alone as negative controls or with 0.1 µg of LPS per ml as a positive control. To assay IFN- induction by
these supernatants, bovine PBMCs were cultured for 48 h with PHA
and either M supernatants diluted 1:2 or rHuIL-12 (0.001 to 1.0 ng
per ml) to create a standard curve. Supernatants from PBMCs cultured
with medium or PHA alone served as negative controls. All supernatants
were analyzed for IFN- production by ELISA. Results are presented as
the mean ± 1 SD of duplicate determinations. The data are
representative of two independent experiments. *, P < 0.01, for M cultured with LPS compared to M cultured with
medium. #, P < 0.01, for M cultured with IRBCs
compared to M cultured with URBCs or URBCs plus IFN- .
|
|
The presence of biologically active IL-1 in M

supernatants was also
evaluated based on the ability of IL-1 to enhance PHA-driven
proliferation of mouse thymocytes. Supernatants from M

cultured
with
URBCs in the absence or presence of IFN-

and M

cultured
with
B. bovis-infected erythrocytes in the absence of IFN-

failed
to enhance PHA-driven thymocyte proliferation (data not shown).
However, IL-1 activity was detected in supernatants diluted 1:4
from
M

cultured with
B. bovis-infected erythrocytes in the
presence
of IFN-

(3,162 ± 800 [mean ± SD] cpm
incorporated compared to
the response to PHA alone [1,097 ± 235 cpm]). A 1:2 dilution was
inhibitory for mouse thymocytes. As a
positive control, 1 ng of
HuIL-1

per ml resulted in optimal
proliferation of 2,058 ± 206
(mean ± SD) cpm. These results
suggested that although bovine
IL-1 was detectable, the mouse thymocyte
costimulation assay was
not very sensitive in our hands. This may also
account for the
failure to detect IL-1 activity in cultures of M

and
B. bovis in the absence of exogenous IFN-

.
Together these data indicate that
B. bovis not only
stimulates iNOS and NO production by M

(
37) but also
stimulates the
production of inflammatory cytokines. At the transcript
and protein
levels, the requirement for exogenously added IFN-

was
not absolute
but varied with each M

preparation. We interpret this
to indicate
that the apparent requirement for IFN-

in some
experiments may
reflect a threshold effect, in which the activation
state of the
M

at the time of the assay determines whether IFN-

is needed
as a cofactor with
B. bovis to stimulate cytokine
expression.
Induction of NO production and iNOS by a lipid fraction of B. bovis-infected erythrocytes.
Because a membrane-enriched
fraction of B. bovis merozoites stimulated the highest level
of NO production by M
(37), we hypothesized that a lipid
component was responsible for this activity. Lipids extracted from
B. bovis-infected erythrocytes induced significantly greater
(P < 0.05) NO production by M
when compared to
lipids from URBCs (Fig. 4A). The positive
control, LPS plus IFN-
, yielded 82.6 ± 4.0 (mean ± SD)
µM NO2
. The induced NO production was
resistant to the addition of polymyxin B, indicating that endotoxin
contamination was not a contributing factor. L-NMMA blocked
lipid-induced NO production, demonstrating that NO production was iNOS
dependent. The lack of NO induction by lipids from URBCs suggests that
the active molecules are of parasite origin. In support of this, all
lipid modifications observed in B. bovis-infected
erythrocyte membranes were shown to be produced through the
biosynthetic activity of the parasite (15). Together, these
data indicate that a B. bovis lipid component is capable of
activating M
.


View larger version (62K):
[in this window]
[in a new window]
|
FIG. 4.
Lipids from B. bovis-infected erythrocytes
induce NO production and transcription of iNOS mRNA by bovine M . (A)
Lipids from URBCs and IRBCs were cultured for 2 days with M at the
indicated concentrations. NO production was assessed using the Griess
assay. Results are presented as the mean ± 1 SD of two
independent experiments. *, P < 0.05, for M
cultured with IRBCs compared to M cultured with lipid from URBCs; #,
P < 0.05, for M cultured with IRBCs compared to
M cultured with B. bovis lipid, but without
L-NMMA. (B) Bovine M were cultured for 6 h with
lipids from URBCs and IRBCs in the presence or absence of IFN- (50 U
per ml). RNA was isolated, subjected to DNase treatment, and analyzed
by RT-PCR.
|
|
The ability of parasite lipids to induce inflammatory cytokine and iNOS
transcripts was also determined. Surprisingly, we
did not observe
enhanced transcription of either TNF-

or IL-12
p35 or p40 mRNA upon
exposure to
B. bovis lipids, whereas iNOS
transcription was
induced following exposure to IRBC lipids in
the absence or presence of
IFN-

, relative to the URBC controls
(Fig.
4B). While the
B. bovis lipid preparation was clearly capable
of activating NO
production by M

, the effect was observed only
when using 125 µg of
lipid per ml, indicating that the stimulatory
component comprised a
minor fraction of the total preparation.
Among protozoal lipids known
to activate M

are parasite membrane-derived
glycolipids, including
glycosylphosphatidylinositol (GPI) moieties.
In murine malaria,
purified
Plasmodium toxin, identified as a
GPI molecule, was
sufficient to induce iNOS expression and production
of NO, TNF-

, and
IL-1 by M

(
2,
33,
38). Furthermore,
GPI-associated lipid
molecules from
T. cruzi and protein-associated
glycolipids
from
T. gondii induced IL-12 production by murine
M

(
18). In contrast,
Leishmania promastigotes and
lipophosphoglycan
molecules derived therefrom failed to stimulate M

(reviewed in
reference
18). With
B. bovis, it is possible that the lipid
extract had an inhibitory
effect on cytokine expression and that
other parasite molecules, such
as DNA (
6), induce cytokine
expression.
Role of NO in inhibition of B. bovis growth by B. bovis-activated M
.
SNP was used as a chemical donor of NO
to confirm the ability of NO to inhibit the growth of B. bovis in vitro (19). A dose-dependent growth inhibition
was observed, for which a maximal inhibition of approximately 80% was
observed with 1,000 µM SNP (Fig. 5). SNP-derived NO2
levels in the parasite
cultures fell within the biologically relevant range of 10 to 25 µM
that is routinely produced by M
stimulated with B. bovis
components (37) (Fig. 4).

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 5.
SNP, a chemical donor of NO, inhibits growth of B. bovis at concentrations that are biologically relevant. Inhibition
of B. bovis growth was assessed in quadruplicate cultures by
measuring incorporation of [3H]hypoxanthine (squares).
SNP-derived NO production from quadruplicate wells was assessed using
the Griess assay (circles). Results for both experiments are shown as
the sample means ± 1 SD and are representative of three
independent experiments.
|
|
Next,
B. bovis growth inhibition by bovine M

was measured
under conditions that permitted phagocytosis of the IRBCs. When
B. bovis-infected erythrocytes were cocultured with M

,
growth
of the parasite was reproducibly inhibited relative to growth
in
the absence of M

(Table
2). The
addition of 250 µM
L-NMMA
partially, but significantly
(
P < 0.05), restored parasite growth,
indicating that
M

-induced inhibition of
B. bovis growth is only
partially
dependent on NO. Addition of IFN-

did not significantly
enhance
growth inhibition of
B. bovis by M

(data not shown),
demonstrating that
B. bovis-infected erythrocytes were
sufficient
to induce phagocytosis and NO production by bovine M

.
Furthermore,
IFN-

had no direct inhibitory activity on
B. bovis (data not
shown).
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Inhibition of B. bovis by bovine M in a
phagocytosis-permissive system is partially reversible by the addition
of L-NMMA
|
|
Finally, to eliminate the effects of phagocytosis on parasite growth
inhibition, a two-compartment system separating parasites
from M

was
employed. Under these conditions, soluble factors
released by M

inhibited the growth of
B. bovis by 16 to 35% (Fig.
6). Addition of
L-NMMA
resulted in significant, but not always
complete, restoration of
parasite growth (Fig.
6), supporting
the conclusion that growth
inhibitory molecules in addition to
NO are produced in response to
B. bovis.

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 6.
Inhibition of B. bovis by bovine M in a
system that does not permit phagocytosis is partially NO dependent.
Bovine M were plated in cell culture inserts and separated from
IRBCs in the wells of a 24-well plate by a 0.4-µm-pore-size membrane
without (white bars) or with (black bars) L-NMMA.
Quadruplicate aliquots of IRBCs were transferred to a 96-well plate.
Inhibition of parasite growth was assessed by measuring parasite
incorporation of [3H]hypoxanthine. Results from two
separate experiments performed with M from different cattle are
shown as the sample means ± 1 SD for each experiment. *,
P < 0.05, for B. bovis cultured with
L-NMMA compared to B. bovis cultured with M
but without L-NMMA.
|
|
Concluding remarks.
This study demonstrates for the first time
that B. bovis induces M
inflammatory and regulatory
cytokines IL-1
, IL-12, and TNF-
that are hypothesized to be
important for both innate and acquired immune responses against this
parasite (9). In cattle, TNF-
is an important cofactor
with IFN-
for NO production by M
(1, 19, 26), although
it does not exhibit direct babesiacidal activity (reference
39 and data not shown). IL-12 stimulates NK cells to
produce IFN-
(41), and in cattle it was shown to stimulate IFN-
production during priming (44) and to
enhance IFN-
production by memory/effector CD4+ T cells
specific for B. bovis (4, 42). Ex vivo production of IFN-
and TNF-
by PBMCs correlated with the resolution of acute
infection in calves vaccinated with a recombinant B. bovis antigen and subsequently challenged (11). In addition to
activating M
, IFN-
enhances production of opsonizing
immunoglobulin G2 antibody in cattle (8, 13, 27), which is
believed to facilitate removal of parasitized erythrocytes
(9). IL-1 enhances the expression of IL-2 receptors on
antigen-specific helper T cells, thereby promoting their expansion in
response to autocrine IL-2 (10).
We also report for the first time that a lipid fraction of
B. bovis-infected erythrocytes induces NO production by bovine
M

.
Previous studies showed that a membrane-enriched fraction
of
B. bovis merozoites stimulated NO production (
37).
Together,
these results are consistent with the potential for GPI
molecules,
believed to anchor certain membrane proteins of
B. bovis (
22),
to activate M

. Further studies are
needed to verify the identities
of the lipids
involved.
NO, induced in M

by
B. bovis, was only partially growth
inhibitory for this parasite, indicating that NO is not solely
responsible
for control of
Babesia replication. When
parasites and M

were
physically separated,
L-NMMA
reversed growth inhibition by more
than 50%, whereas when parasites
were allowed to be phagocytosed,
the effect of
L-NMMA was
less striking. These observations support
the in vivo data of Gale et
al. (
17), who found that administration
of an iNOS inhibitor
ameliorated some of the symptoms of acute
B. bovis
infection, but had a limited and inconsistent effect
on parasitemia.
These results suggested that NO was produced during
acute infection but
that it might not be sufficient to limit parasite
replication.
B. bovis paradoxically stimulates an innate immune response
that could result in the control of acute infection and survival
of the
host. However, for this parasite, which can cause a virulent
and often
fatal cerebral form of disease, success is measured
by the ability to
maintain a persistent infection that results
when cattle naturally
survive acute infection (
25). Persistently
infected animals
provide a reservoir for subsequent transmission
by ticks to susceptible
animals. The ability to stimulate protective,
innate immune responses
used naturally by the pathogen may be
a key factor in designing vaccine
adjuvants and delivery systems
for the prevention of
babesiosis.
 |
ACKNOWLEDGMENTS |
We thank Deb Alperin and Kim Kegerreis for excellent technical assistance.
This research was supported by NIH NIAID grant R01-AI30136 (W.C.B.),
USDA NRICGP grants 96-35204-3667 (G.H.P.) and 98-35204-6737 (L.K.M.S.),
and by the Organization of American States Fellowship Program
(J.F.-C.).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Program in
Vector-Borne Diseases, Department of Veterinary Microbiology and
Pathology, Washington State University, Pullman, WA 99164-7040. Phone:
(509) 335-6067. Fax: (509) 335-8529. E-mail:
wbrown{at}vetmed.wsu.edu.
Editor:
R. N. Moore
 |
REFERENCES |
| 1.
|
Adler, H.,
E. Peterhans,
J. Nicolet, and T. W. Jungi.
1994.
Inducible L-arginine-dependent nitric oxide synthase activity in bovine bone marrow-derived macrophages.
Biochem. Biophys. Res. Commun.
198:510-515[CrossRef][Medline].
|
| 2.
|
Bate, C. A. W.,
J. Taverne,
E. Roman,
C. Moreno, and J. H. L. Playfair.
1992.
Tumor necrosis factor induction by malaria exoantigens depends upon phospholipid.
Immunology
75:129-135[Medline].
|
| 3.
|
Bligh, E. G., and W. J. Dyer.
1959.
A rapid method of total lipid extraction and purification.
Can. J. Biochem. Physiol.
37:911-917.
|
| 4.
|
Brown, W. C.,
W. C. Davis, and W. Tuo.
1996.
Human interleukin-12 upregulates proliferation and interferon- production by parasite antigen-stimulated Th cell clones and / T cells of cattle.
Annu. N.Y. Acad. Sci.
795:321-324[Medline].
|
| 5.
|
Brown, W. C., and D. M. Estes.
1997.
Type 1 and type 2 responses in cattle and their regulation, p. 15-33.
In
V. E. C. J. Schijns, and M. C. Horzinek (ed.), Cytokines in veterinary medicine. CAB International, New York, N.Y.
|
| 6.
|
Brown, W. C.,
D. M. Estes,
S. E. Chantler,
K. A. Kegerreis, and C. E. Suarez.
1998.
DNA and a CpG oligonucleotide derived from Babesia bovis are mitogenic for bovine B cells.
Infect. Immun.
66:5423-5432[Abstract/Free Full Text].
|
| 7.
|
Brown, W. C.,
K. S. Logan,
G. G. Wagner, and C. L. Tetzlaff.
1991.
Cell-mediated immune responses to Babesia bovis merozoite antigens in cattle following infection with tick-derived or cultured parasites.
Infect. Immun.
59:2418-2426[Abstract/Free Full Text].
|
| 8.
|
Brown, W. C.,
T. F. McElwain,
G. H. Palmer,
S. E. Chantler, and D. M. Estes.
1999.
Bovine CD4+ T-lymphocyte clones specific for rhoptry-associated protein 1 of Babesia bigemina stimulate enhanced immunoglobulin G1 (IgG1) and IgG2 synthesis.
Infect. Immun.
67:155-164[Abstract/Free Full Text].
|
| 9.
|
Brown, W. C., and G. H. Palmer.
1999.
Designing blood-stage vaccines against Babesia bovis and B. bigemina.
Parasitol. Today
15(7):275-281[CrossRef][Medline].
|
| 10.
|
Dinarello, C. A.
1992.
Role of interleukin-1 in infectious diseases.
Immunol. Rev.
127:120-146.
|
| 11.
|
East, I. J.,
H. Zakrzewski,
K. R. Gale,
G. Leatch,
C. M. Dimmock,
M. B. Thomas, and D. J. Waltisbuhl.
1997.
Vaccination against Babesia bovis: T cells from protected and unprotected animals show different cytokine profiles.
Int. J. Parasitol.
27:1537-1545[CrossRef][Medline].
|
| 12.
|
Ellis, J. A.,
D. Godson,
M. Campos,
M. Sileghem, and L. A. Babiuk.
1993.
Capture immunoassay for ruminant tumor necrosis factor- : comparison with bioassay.
Vet. Immunol. Immunopathol.
35:289-300[CrossRef][Medline].
|
| 13.
|
Estes, D. M.,
N. M. Closser, and G. K. Allen.
1994.
IFN- stimulates IgG2 production from bovine B cells costimulated with anti-µ and mitogen.
Cell. Immunol.
154:287-295[CrossRef][Medline].
|
| 14.
|
Fell, A., and N. Smith.
1998.
Immunity to asexual blood stages of Plasmodium: is resistance to acute malaria adaptive or innate?
Parasitol. Today
14(9):364-369.
|
| 15.
|
Florin-Christensen, J.,
C. E. Suarez,
M. Florin-Christensen,
S. A. Hines,
T. F. Mcelwain, and G. H. Palmer.
2000.
Phosphatidylcholine formation is the predominant lipid biosynthetic event in the hemoparasite Babesia bovis.
Mol. Biochem. Parasitol.
106:147-156[CrossRef][Medline].
|
| 16.
|
Frankova, D., and Z. Zidek.
1998.
IFN- -induced TNF- is a prerequisite for in vitro production of nitric oxide generated in murine peritoneal macrophages by IFN- .
Eur. J. Immunol.
28:838-843[CrossRef][Medline].
|
| 17.
|
Gale, K. R.,
D. J. Waltisbuhl,
J. M. Bowden,
W. K. Jorgensen,
J. Matheson,
I. J. East,
H. Zakrzewski, and G. Leatch.
1998.
Amelioration of virulent Babesia bovis infection in calves by administration of the nitric oxide synthase inhibitor aminoguanidine.
Parasite Immunol.
20:441-445[CrossRef][Medline].
|
| 18.
|
Gazzinelli, R. T.,
M. M. Camargo,
I. C. Almeida,
Y. S. Morita,
M. Giraldo,
A. Acosta-Serrano,
S. Hieny,
P. T. Englund,
M. A. J. Ferguson,
L. R. Travassos, and A. Sher.
1997.
Identification and characterization of protozoan products that trigger the synthesis of IL-12 by inflammatory macrophages.
Chem. Immunol.
68:136-152[Medline].
|
| 19.
|
Goff, W. L.,
W. C. Johnson,
C. R. Wyatt, and C. W. Cluff.
1996.
Assessment of bovine mononuclear phagocytes and neutrophils for induced L-arginine-dependent nitric oxide production.
Vet. Immunol. Immunopathol.
55:45-62[CrossRef][Medline].
|
| 20.
|
Goff, W. L., and C. E. Yunker.
1986.
Babesia bovis: increased percentage of parasitized erythrocytes in cultures and assessment of growth by incorporation of [3H]hypoxanthine.
Exp. Parasitol.
62:202-210[CrossRef][Medline].
|
| 21.
|
Grau, G. E.,
P.-F. Piguet,
P. Vassalli, and P.-H. Lambert.
1989.
Tumor necrosis factor and other cytokines in cerebral malaria: experimental and clinical data.
Immunol. Rev.
112:49-70[CrossRef][Medline].
|
| 22.
|
Hines, S. A.,
T. F. McElwain,
G. M. Buening, and G. H. Palmer.
1989.
Molecular characterization of Babesia bovis merozoite surface proteins bearing epitopes immunodominant in protected cattle.
Mol. Biochem. Parasitol.
37:1-10[CrossRef][Medline].
|
| 23.
|
Johnson, W. C.,
C. W. Cluff,
W. L. Goff, and C. R. Wyatt.
1996.
Reactive oxygen and nitrogen intermediates and products from polyamine degradation are babesiacidal in vitro.
Annu. N.Y. Acad. Sci.
791:136-147[Medline].
|
| 24.
|
Kumaratilake, L. M.,
A. Ferrante, and C. M. Rzepcayk.
1990.
Tumor necrosis factor enhances neutrophil-mediated killing of Plasmodium falciparum.
Infect. Immun.
58:788-793[Abstract/Free Full Text].
|
| 25.
|
Mahoney, D. F.,
I. G. Wright, and G. B. Mirre.
1973.
Bovine babesiosis: the persistence of immunity to Babesia argentine and B. bigemina in calves (Bos taurus) after naturally acquired infection.
Ann. Trop. Med. Parasitol.
67:197-203[Medline].
|
| 26.
|
Mason, G. L.,
Z. Yang,
T. W. J. Olchowy,
Z. Jian, and P. N. Bochsler.
1996.
Nitric oxide production and expression of inducible nitric oxide synthase by bovine alveolar macrophages.
Vet. Immunol. Immunopathol.
53:15-27[CrossRef][Medline].
|
| 27.
|
McGuire, T. C.,
A. J. Musoke, and T. Kurtti.
1979.
Functional properties of bovine IgG1 and IgG2: interaction with complement, macrophages, neutrophils and skin.
Immunology
38:249-256[Medline].
|
| 28.
|
Montealegre, F.,
M. G. Levy,
M. Ristic, and M. A. James.
1985.
Growth inhibition of Babesia bovis in culture by secretions from bovine mononuclear phagocytes.
Infect. Immun.
50:523-526[Abstract/Free Full Text].
|
| 29.
|
Quakyi, I. A.,
J. Currier,
A. Fell,
D. W. Taylor,
T. Roberts,
R. A. Houghten,
R. D. England,
J. A. Berzofsky,
L. H. Miller, and M. F. Good.
1994.
Analysis of human T cell clones specific for conserved peptide sequences within malaria proteins.
J. Immunol.
153:2082-2092[Abstract].
|
| 30.
|
Robinson, D.,
K. Shibuya,
A. Mui,
F. Zonin,
E. Murphy,
T. Sana,
S. B. Hartley,
S. Menon,
R. Kastelein,
F. Bazan, and A. O'Garra.
1997.
IGIF does not drive Th1 development but synergizes with IL-12 for interferon- production and activates IRAK and NF B.
Immunity
7:571-581[CrossRef][Medline].
|
| 31.
|
Rockett, K. A.,
M. M. Awburn,
W. B. Cowden, and I. A. Clark.
1991.
Killing of Plasmodium falciparum in vitro by nitric oxide derivatives.
Infect. Immun.
59:3280-3283[Abstract/Free Full Text].
|
| 32.
|
Rockett, K. A.,
D. Kwiatkowski,
C. A. W. Bate,
M. M. Awburn,
E. J. Rockett, and I. A. Clark.
1996.
In vitro induction of nitric oxide by an extract of Plasmodium falciparum.
J. Infect.
32:187-196[CrossRef][Medline].
|
| 33.
|
Schofield, L., and F. Hackett.
1993.
Signal transduction in host cells by a glycosylphosphatidylinositol toxin of malaria parasites.
J. Exp. Med.
177:145-153[Abstract/Free Full Text].
|
| 34.
|
Schofield, L.,
S. Novakovic,
P. Gerold,
R. T. Schwarz,
M. J. McConville, and S. D. Tachado.
1996.
Glycosylphosphatidylinositol toxin of Plasmodium upregulates intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin expression in vascular endothelial cells and increases leukocyte and parasite cytoadherence via tyrosine kinase-dependent signal transduction.
J. Immunol.
156:1886-1896[Abstract].
|
| 35.
|
Scragg, I. G.,
M. Hensmann,
C. A. Bate, and D. Kwiatkowski.
1999.
Early cytokine induction by Plasmodium falciparum is not a classical endotoxin-like process.
Eur. J. Immunol.
29:2636-2644[CrossRef][Medline].
|
| 36.
|
Shoda, L. K. M.,
D. S. Zarlenga,
A. Hirano, and W. C. Brown.
1999.
Cloning of a cDNA encoding bovine IL-18.
J. Interferon Cytokine Res.
19:1169-1177[CrossRef][Medline].
|
| 37.
|
Stich, R. W.,
L. K. M. Shoda,
M. Dreewes,
B. Adler,
T. W. Jungi, and W. C. Brown.
1998.
Stimulation of nitric oxide production in macrophages by Babesia bovis.
Infect. Immun.
66:4130-4136[Abstract/Free Full Text].
|
| 38.
|
Tachado, S. D.,
P. Gerold,
M. J. McConville,
T. Baldwin,
D. Quilici,
R. T. Schwarz, and L. Schofield.
1996.
Glycosylphosphatidylinositol toxin of Plasmodium induces nitric oxide synthase expression in macrophages and vascular endothelial cells by a protein tyrosine kinase-dependent and protein kinase C-dependent signaling pathway.
J. Immunol.
156:1897-1907[Abstract].
|
| 39.
|
Tambrallo, L. J.,
G. M. Buening, and R. M. McLaughlin.
1992.
The effect of neutrophils, tumor necrosis factor, and granulocyte macrophage/colony stimulating factor on Babesia bovis and Babesia bigemina in culture.
Vet. Parasitol.
43:177-188[CrossRef][Medline].
|
| 40.
|
Taylor-Robinson, A. W.
1997.
Antimalarial activity of nitric oxide: cytostasis and cytotoxicity towards Plasmodium falciparum.
Biochem. Soc. Trans.
25:262S[Medline].
|
| 41.
|
Trinchieri, G.
1995.
Interleukin 12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity.
Annu. Rev. Immunol.
13:251-276[Medline].
|
| 42.
|
Tuo, W.,
D. M. Estes, and W. C. Brown.
1999.
Comparative effects of IL-12 and IL-4 on cytokine expression by antigen-stimulated memory CD4+ T cells of cattle: IL-12 enhances IFN- production, but IL-4 has marginal effects on cytokine expression.
J. Interferon Cytokine Res.
19:743-751.
|
| 43.
|
Tuo, W.,
H. Macmillan,
N. Gunter,
F. W. Bazer, and W. C. Brown.
1999.
Upregulation of interleukin-4 and IFN- expression by IFN- , a member of the type 1 IFN family.
J. Interferon Cytokine Res.
19:179-187[CrossRef][Medline].
|
| 44.
|
Tuo, W.,
G. H. Palmer,
T. C. McGuire,
D. Zhu, and W. C. Brown.
2000.
Interleukin-12 as an adjuvant promotes immunoglobulin G and type 1 cytokine recall responses to major surface protein 2 of the ehrlichial pathogen Anaplasma marginale.
Infect. Immun.
68:270-280[Abstract/Free Full Text].
|
| 45.
|
Wright, I. G.,
B. V. Goodger, and I. A. Clark.
1988.
Immunopathophysiology of Babesia bovis and Plasmodium falciparum infections.
Parasitol. Today
4:214-218.
|
Infection and Immunity, September 2000, p. 5139-5145, Vol. 68, No. 9
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Han, S., Norimine, J., Palmer, G. H., Mwangi, W., Lahmers, K. K., Brown, W. C.
(2008). Rapid Deletion of Antigen-Specific CD4+ T Cells following Infection Represents a Strategy of Immune Evasion and Persistence for Anaplasma marginale. J. Immunol.
181: 7759-7769
[Abstract]
[Full Text]
-
Lahmers, K. K., Hedges, J. F., Jutila, M. A., Deng, M., Abrahamsen, M. S., Brown, W. C.
(2006). Comparative gene expression by WC1+ {gamma}{delta} and CD4+ {alpha}{beta} T lymphocytes, which respond to Anaplasma marginale, demonstrates higher expression of chemokines and other myeloid cell-associated genes by WC1+ {gamma}{delta} T cells.. J. Leukoc. Biol.
80: 939-952
[Abstract]
[Full Text]
-
Norimine, J., Mosqueda, J., Palmer, G. H., Lewin, H. A., Brown, W. C.
(2004). Conservation of Babesia bovis Small Heat Shock Protein (Hsp20) among Strains and Definition of T Helper Cell Epitopes Recognized by Cattle with Diverse Major Histocompatibility Complex Class II Haplotypes. Infect. Immun.
72: 1096-1106
[Abstract]
[Full Text]
-
Norimine, J., Mosqueda, J., Suarez, C., Palmer, G. H., McElwain, T. F., Mbassa, G., Brown, W. C.
(2003). Stimulation of T-Helper Cell Gamma Interferon and Immunoglobulin G Responses Specific for Babesia bovis Rhoptry-Associated Protein 1 (RAP-1) or a RAP-1 Protein Lacking the Carboxy-Terminal Repeat Region Is Insufficient To Provide Protective Immunity against Virulent B. bovis Challenge. Infect. Immun.
71: 5021-5032
[Abstract]
[Full Text]
-
Aguilar-Delfin, I., Wettstein, P. J., Persing, D. H.
(2003). Resistance to Acute Babesiosis Is Associated with Interleukin-12- and Gamma Interferon-Mediated Responses and Requires Macrophages and Natural Killer Cells. Infect. Immun.
71: 2002-2008
[Abstract]
[Full Text]
-
Norimine, J., Suarez, C. E., McElwain, T. F., Florin-Christensen, M., Brown, W. C.
(2002). Immunodominant Epitopes in Babesia bovis Rhoptry-Associated Protein 1 That Elicit Memory CD4+-T-Lymphocyte Responses in B. bovis-Immune Individuals Are Located in the Amino-Terminal Domain. Infect. Immun.
70: 2039-2048
[Abstract]
[Full Text]
-
Shoda, L. K. M., Kegerreis, K. A., Suarez, C. E., Mwangi, W., Knowles, D. P., Brown, W. C.
(2001). Immunostimulatory CpG-modified plasmid DNA enhances IL-12, TNF-{alpha}, and NO production by bovine macrophages. J. Leukoc. Biol.
70: 103-112
[Abstract]
[Full Text]
-
Shoda, L. K. M., Kegerreis, K. A., Suarez, C. E., Roditi, I., Corral, R. S., Bertot, G. M., Norimine, J., Brown, W. C.
(2001). DNA from Protozoan Parasites Babesia bovis, Trypanosoma cruzi, and T. brucei Is Mitogenic for B Lymphocytes and Stimulates Macrophage Expression of Interleukin-12, Tumor Necrosis Factor Alpha, and Nitric Oxide. Infect. Immun.
69: 2162-2171
[Abstract]
[Full Text]